Back to today’s briefing

Story perspectives

Breakthrough Reveals Key Proteins in Deadly Prostate Cancer

7/26/2025

50 10

Summary

Story summary

Emory researchers have unveiled a groundbreaking process that reveals how prostate cancer morphs into its deadliest form, neuroendocrine prostate cancer (NEPC), impacting 20% of advanced cases. By pinpointing crucial proteins behind this transformation, they are paving the way for innovative treatments with CBP/p300 inhibitors, offering new hope for patients battling this aggressive disease.

1 of 1

Story summary

Emory researchers have unveiled a groundbreaking process that reveals how prostate cancer morphs into its deadliest form, neuroendocrine prostate cancer (NEPC), impacting 20% of advanced cases. By pinpointing crucial proteins behind this transformation, they are paving the way for innovative treatments with CBP/p300 inhibitors, offering new hope for patients battling this aggressive disease.